Genitourinary cancer.
Hudes
G R
GR
Ozols
R F
RF
Schilder
R J
RJ
D000951:Antigens, Neoplasm / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D016190:Carboplatin / Q000627:therapeutic use; D002292:Carcinoma, Renal Cell / Q000188:drug therapy / Q000628:therapy; D003131:Combined Modality Therapy; D004407:Dysgerminoma / Q000188:drug therapy / Q000628:therapy; D005260:Female; D006801:Humans; D007680:Kidney Neoplasms / Q000188:drug therapy / Q000628:therapy; D008297:Male; D011379:Prognosis; D017430:Prostate-Specific Antigen; D011471:Prostatic Neoplasms / Q000188:drug therapy / Q000628:therapy; D013736:Testicular Neoplasms / Q000188:drug therapy / Q000628:therapy; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy / Q000628:therapy; D014565:Urogenital Neoplasms / Q000188:drug therapy / Q000628:therapy*
D000951:Antigens, Neoplasm; D000970:Antineoplastic Agents; D016190:Carboplatin; D017430:Prostate-Specific Antigen